{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:53:37Z","timestamp":1771232017662,"version":"3.50.1"},"publisher-location":"Cham","reference-count":93,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030216368","type":"print"},{"value":"9783030217358","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-21735-8_2","type":"book-chapter","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T13:03:27Z","timestamp":1569589407000},"page":"3-12","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Understanding the Role of Pro-resolving Lipid Mediators in Infectious Keratitis"],"prefix":"10.1007","author":[{"given":"Elizabeth A.","family":"Berger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,28]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/00003226-200104000-00010","volume":"20","author":"T Rattanatam","year":"2001","unstructured":"Rattanatam T, Heng WJ, Rapuano CJ, Laibson PR, Cohen EJ (2001) Trends in contact lens-related corneal ulcers. Cornea 20:290\u2013294","journal-title":"Cornea"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"e0181343","DOI":"10.1371\/journal.pone.0181343","volume":"12","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Naduvilath T, Keay L, Radford C, Dart J, Edwards K, Carnt N, Minassian D, Holden B (2017) Risk factors and causative organisms in microbial keratitis in daily disposable contact lens wear. PLoS One 12:e0181343","journal-title":"PLoS One"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/ICO.0b013e318156caf2","volume":"27","author":"M Green","year":"2008","unstructured":"Green M, Apel A, Stapleton F (2008) Risk factors and causative organisms in microbial keratitis. Cornea 27:22\u201327","journal-title":"Cornea"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/ICL.0b013e318157c49d","volume":"33","author":"L Keay","year":"2007","unstructured":"Keay L, Stapleton F, Schein O (2007) Epidemiology of contact lens-related inflammation and microbial keratitis: a 20-year perspective. Eye Contact Lens 33:346\u2013353. discussion 362\u2013343","journal-title":"Eye Contact Lens"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1442-9071.1992.tb00718.x","volume":"20","author":"B Thylefors","year":"1992","unstructured":"Thylefors B (1992) Epidemiological patterns of ocular trauma. Aust N Z J Ophthalmol 20:95\u201398","journal-title":"Aust N Z J Ophthalmol"},{"key":"2_CR6","first-page":"557","volume":"7","author":"XL Sheng","year":"2014","unstructured":"Sheng XL, Li HP, Liu QX, Rong WN, Du WZ, Ma L, Yan GH, Ma RQ, Zhang JL, Xu HF, Zou WQ, Bi XJ (2014) Prevalence and associated factors of corneal blindness in Ningxia in Northwest China. Int J Ophthalmol 7:557\u2013562","journal-title":"Int J Ophthalmol"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4103\/0974-620X.57310","volume":"2","author":"S Saha","year":"2009","unstructured":"Saha S, Banerjee D, Khetan A, Sengupta J (2009) Epidemiological profile of fungal keratitis in urban population of West Bengal, India. Oman J Ophthalmol 2:114\u2013118","journal-title":"Oman J Ophthalmol"},{"key":"2_CR8","first-page":"1778","volume":"111","author":"PK Nirmalan","year":"2004","unstructured":"Nirmalan PK, Katz J, Tielsch JM, Robin AL, Thulasiraj RD, Krishnadas R, Ramakrishnan R (2004) Ocular trauma in a rural south Indian population: the Aravind comprehensive eye survey. Ophthalmology 111:1778\u20131781","journal-title":"Ophthalmology"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S0161-6420(81)34943-4","volume":"88","author":"DB Jones","year":"1981","unstructured":"Jones DB (1981) Decision-making in the management of microbial keratitis. Ophthalmology 88:814\u2013820","journal-title":"Ophthalmology"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2003.10.002","volume":"23","author":"LD Hazlett","year":"2004","unstructured":"Hazlett LD (2004) Corneal response to Pseudomonas aeruginosa infection. Prog Retin Eye Res 23:1\u201330","journal-title":"Prog Retin Eye Res"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/89759","volume":"2","author":"BD Levy","year":"2001","unstructured":"Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2:612","journal-title":"Nat Immunol"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","volume":"192","author":"CN Serhan","year":"2000","unstructured":"Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K (2000) Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 192:1197\u20131204","journal-title":"J Exp Med"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.20020760","volume":"196","author":"CN Serhan","year":"2002","unstructured":"Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196:1025\u20131037","journal-title":"J Exp Med"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"14677","DOI":"10.1074\/jbc.M300218200","volume":"278","author":"S Hong","year":"2003","unstructured":"Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN (2003) Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem 278:14677\u201314687","journal-title":"J Biol Chem"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nm.2123","volume":"16","author":"ZZ Xu","year":"2010","unstructured":"Xu ZZ, Zhang L, Liu T, Park JY, Berta T, Yang R, Serhan CN, Ji RR (2010) Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med 16:592\u2013597. 591p following 597","journal-title":"Nat Med"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1182\/blood-2012-04-423525","volume":"120","author":"J Dalli","year":"2012","unstructured":"Dalli J, Serhan CN (2012) Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 120:e60\u2013e72","journal-title":"Blood"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nature05877","volume":"447","author":"JM Schwab","year":"2007","unstructured":"Schwab JM, Chiang N, Arita M, Serhan CN (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447:869\u2013874","journal-title":"Nature"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2017.03.006","volume":"58","author":"J Wei","year":"2017","unstructured":"Wei J, Gronert K (2017) The role of pro-resolving lipid mediators in ocular diseases. Mol Asp Med 58:37\u201343","journal-title":"Mol Asp Med"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"15267","DOI":"10.1074\/jbc.M410638200","volume":"280","author":"K Gronert","year":"2005","unstructured":"Gronert K, Maheshwari N, Khan N, Hassan IR, Dunn M, Laniado Schwartzman M (2005) A role for the mouse 12\/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem 280:15267\u201315278","journal-title":"J Biol Chem"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1100\/tsw.2010.99","volume":"10","author":"EL Liclican","year":"2010","unstructured":"Liclican EL, Gronert K (2010) Molecular circuits of resolution in the eye. Scientific World J 10:1029\u20131047","journal-title":"Scientific World J"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.plefa.2005.05.009","volume":"73","author":"K Gronert","year":"2005","unstructured":"Gronert K (2005) Lipoxins in the eye and their role in wound healing. Prostaglandins Leukot Essent Fatty Acids 73:221\u2013229","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1194\/jlr.R001347","volume":"51","author":"S Kenchegowda","year":"2010","unstructured":"Kenchegowda S, Bazan HE (2010) Significance of lipid mediators in corneal injury and repair. J Lipid Res 51:879\u2013891","journal-title":"J Lipid Res"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1096\/fj.201701502R","volume":"32","author":"TW Carion","year":"2018","unstructured":"Carion TW, Greenwood M, Ebrahim AS, Jerome A, Suvas S, Gronert K, Berger EA (2018) Immunoregulatory role of 15-lipoxygenase in the pathogenesis of bacterial keratitis. FASEB J 32:5026\u20135038","journal-title":"FASEB J"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"e24422","DOI":"10.1371\/journal.pone.0024422","volume":"6","author":"G Fredman","year":"2011","unstructured":"Fredman G, Oh SF, Ayilavarapu S, Hasturk H, Serhan CN, Van Dyke TE (2011) Impaired phagocytosis in localized aggressive periodontitis: rescue by Resolvin E1. PLoS One 6:e24422","journal-title":"PLoS One"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"318621","DOI":"10.1155\/2012\/318621","volume":"2012","author":"R Settimio","year":"2012","unstructured":"Settimio R, Clara DF, Franca F, Francesca S, Michele D (2012) Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis. Mediat Inflamm 2012:318621","journal-title":"Mediat Inflamm"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan CN (2014) Pro-resolving lipid mediators are leads for resolution physiology. Nature 510:92\u2013101","journal-title":"Nature"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41385-018-0089-1","volume":"12","author":"DR Saban","year":"2019","unstructured":"Saban DR, Hodges RR, Mathew R, Reyes NJ, Yu C, Kaye R, Swift W, Botten N, Serhan CN, Dartt DA (2019) Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model. Mucosal Immunol 12:145\u2013153","journal-title":"Mucosal Immunol"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.4049\/jimmunol.1000833","volume":"186","author":"DA Dartt","year":"2011","unstructured":"Dartt DA, Hodges RR, Li D, Shatos MA, Lashkari K, Serhan CN (2011) Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. J Immunol 186:4455\u20134466","journal-title":"J Immunol"},{"key":"2_CR29","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1097\/ICO.0b013e3181d2de91","volume":"29","author":"K Makdoumi","year":"2010","unstructured":"Makdoumi K, Mortensen J, Crafoord S (2010) Infectious keratitis treated with corneal crosslinking. Cornea 29:1353\u20131358","journal-title":"Cornea"},{"key":"2_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/ICO.0000000000000644","volume":"35","author":"L Papaioannou","year":"2016","unstructured":"Papaioannou L, Miligkos M, Papathanassiou M (2016) Corneal collagen cross-linking for infectious keratitis: a systematic review and meta-analysis. Cornea 35:62\u201371","journal-title":"Cornea"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1869-5760-3-47","volume":"3","author":"JL Alio","year":"2013","unstructured":"Alio JL, Abbouda A, Valle DD, Del Castillo JM, Fernandez JA (2013) Corneal cross linking and infectious keratitis: a systematic review with a meta-analysis of reported cases. J Ophthalmic Inflamm Infect 3:47","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/archopht.1990.01070090103049","volume":"108","author":"DC Gritz","year":"1990","unstructured":"Gritz DC, Lee TY, Kwitko S, McDonnell PJ (1990) Topical anti-inflammatory agents in an animal model of microbial keratitis. Arch Ophthalmol 108:1001\u20131005","journal-title":"Arch Ophthalmol"},{"key":"2_CR33","first-page":"205","volume":"99","author":"AJ Flach","year":"2001","unstructured":"Flach AJ (2001) Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs. Trans Am Ophthalmol Soc 99:205\u2013210. discussion 210\u2013202","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S0161-6420(00)00538-8","volume":"108","author":"AC Guidera","year":"2001","unstructured":"Guidera AC, Luchs JI, Udell IJ (2001) Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology 108:936\u2013944","journal-title":"Ophthalmology"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/00003226-199209000-00008","volume":"11","author":"DC Gritz","year":"1992","unstructured":"Gritz DC, Kwitko S, Trousdale MD, Gonzalez VH, McDonnell PJ (1992) Recurrence of microbial keratitis concomitant with antiinflammatory treatment in an animal model. Cornea 11:404\u2013408","journal-title":"Cornea"},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.ophtha.2017.05.012","volume":"124","author":"A Austin","year":"2017","unstructured":"Austin A, Lietman T, Rose-Nussbaumer J (2017) Update on the management of infectious keratitis. Ophthalmology 124:1678\u20131689","journal-title":"Ophthalmology"},{"key":"2_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1001\/archophthalmol.2008.503","volume":"127","author":"EJ Cohen","year":"2009","unstructured":"Cohen EJ (2009) The case against the use of steroids in the treatment of bacterial keratitis. Arch Ophthalmol 127:103\u2013104","journal-title":"Arch Ophthalmol"},{"key":"2_CR38","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S0161-6420(02)00963-6","volume":"109","author":"KR Wilhelmus","year":"2002","unstructured":"Wilhelmus KR (2002) Indecision about corticosteroids for bacterial keratitis: an evidence-based update. Ophthalmology 109:835\u2013842. quiz 843","journal-title":"Ophthalmology"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","volume":"25","author":"CN McGhee","year":"2002","unstructured":"McGhee CN, Dean S, Danesh-Meyer H (2002) Locally administered ocular corticosteroids: benefits and risks. Drug Saf 25:33\u201355","journal-title":"Drug Saf"},{"key":"2_CR40","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/eye.2010.231","volume":"25","author":"H Orlans","year":"2011","unstructured":"Orlans H, Hornby S, Bowler I (2011) In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review. Eye 25:489","journal-title":"Eye"},{"key":"2_CR41","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.ophtha.2012.03.031","volume":"119","author":"A Lichtinger","year":"2012","unstructured":"Lichtinger A, Yeung SN, Kim P, Amiran MD, Iovieno A, Elbaz U, Ku JY, Wolff R, Rootman DS, Slomovic AR (2012) Shifting trends in bacterial keratitis in Toronto: an 11-year review. Ophthalmology 119:1785\u20131790","journal-title":"Ophthalmology"},{"key":"2_CR42","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/ICO.0000000000000431","volume":"34","author":"VS Chang","year":"2015","unstructured":"Chang VS, Dhaliwal DK, Raju L, Kowalski RP (2015) Antibiotic resistance in the treatment of Staphylococcus aureus keratitis: a 20-year review. Cornea 34:698\u2013703","journal-title":"Cornea"},{"key":"2_CR43","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12886-017-0612-2","volume":"17","author":"M Teweldemedhin","year":"2017","unstructured":"Teweldemedhin M, Gebreyesus H, Atsbaha AH, Asgedom SW, Saravanan M (2017) Bacterial profile of ocular infections: a systematic review. BMC Ophthalmol 17:212","journal-title":"BMC Ophthalmol"},{"key":"2_CR44","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.ajo.2008.01.025","volume":"145","author":"PA Asbell","year":"2008","unstructured":"Asbell PA, Colby KA, Deng S, McDonnell P, Meisler DM, Raizman MB, Sheppard JD Jr, Sahm DF (2008) Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am J Ophthalmol 145:951\u2013958.e951","journal-title":"Am J Ophthalmol"},{"key":"2_CR45","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ajo.2011.03.010","volume":"152","author":"W Haas","year":"2011","unstructured":"Haas W, Pillar CM, Torres M, Morris TW, Sahm DF (2011) Monitoring antibiotic resistance in ocular microorganisms: results from the ARMOR 2009 surveillance study. Am J Ophthalmol 152:567\u2013574","journal-title":"Am J Ophthalmol"},{"key":"2_CR46","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/bjo.84.3.300","volume":"84","author":"Y Alster","year":"2000","unstructured":"Alster Y, Herlin L, Lazar M, Loewenstein A (2000) Intraocular penetration of vancomycin eye drops after application to the medial canthus with closed lids. Br J Ophthalmol 84:300\u2013302","journal-title":"Br J Ophthalmol"},{"key":"2_CR47","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/338782","volume":"34","author":"DM Livermore","year":"2002","unstructured":"Livermore DM (2002) Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34:634\u2013640","journal-title":"Clin Infect Dis"},{"key":"2_CR48","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1128\/AAC.00762-10","volume":"54","author":"H-C Su","year":"2010","unstructured":"Su H-C, Ramkissoon K, Doolittle J, Clark M, Khatun J, Secrest A, Wolfgang MC, Giddings MC (2010) The development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins. Antimicrob Agents Chemother 54:4626\u20134635","journal-title":"Antimicrob Agents Chemother"},{"key":"2_CR49","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1096\/fj.06-7918com","volume":"21","author":"B Biteman","year":"2007","unstructured":"Biteman B, Hassan IR, Walker E, Leedom AJ, Dunn M, Seta F, Laniado-Schwartzman M, Gronert K (2007) Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing. FASEB J 21:2257\u20132266","journal-title":"FASEB J"},{"key":"2_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2353\/ajpath.2010.090678","volume":"176","author":"AJ Leedom","year":"2010","unstructured":"Leedom AJ, Sullivan AB, Dong B, Lau D, Gronert K (2010) Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury. Am J Pathol 176:74\u201384","journal-title":"Am J Pathol"},{"key":"2_CR51","doi-asserted-by":"publisher","first-page":"6932","DOI":"10.1167\/iovs.15-17315","volume":"56","author":"TW Carion","year":"2015","unstructured":"Carion TW, McWhirter CR, Grewal DK, Berger EA (2015) Efficacy of VIP as treatment for bacteria-induced keratitis against multiple Pseudomonas aeruginosa strains. Invest Ophthalmol Vis Sci 56:6932\u20136940","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2_CR52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.prostaglandins.2018.12.001","volume":"140","author":"TW Carion","year":"2018","unstructured":"Carion TW, Kracht D, Strand E, David E, McWhirter C, Ebrahim AS, Berger EA (2018) VIP modulates the ALX\/FPR2 receptor axis toward inflammation resolution in a mouse model of bacterial keratitis. Prostaglandins Other Lipid Mediat 140:18\u201325","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2_CR53","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.ajpath.2012.01.028","volume":"180","author":"S Krishnamoorthy","year":"2012","unstructured":"Krishnamoorthy S, Recchiuti A, Chiang N, Fredman G, Serhan CN (2012) Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. Am J Pathol 180:2018\u20132027","journal-title":"Am J Pathol"},{"key":"2_CR54","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1167\/iovs.08-2462","volume":"50","author":"Y Jin","year":"2009","unstructured":"Jin Y, Arita M, Zhang Q, Saban DR, Chauhan SK, Chiang N, Serhan CN, Dana R (2009) Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest Ophthalmol Vis Sci 50:4743\u20134752","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2_CR55","doi-asserted-by":"crossref","unstructured":"Carion TW, Ebrahim AS, Kracht D, Agrawal A, Strand E, Kaddurah O, McWhirter CR, Sosne G, Berger EA (2018) Thymosin beta-4 and ciprofloxacin adjunctive therapy improves Pseudomonas aeruginosa-induced keratitis. Cell 7","DOI":"10.3390\/cells7100145"},{"key":"2_CR56","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1167\/iovs.14-15982","volume":"56","author":"JE Lee","year":"2015","unstructured":"Lee JE, Sun Y, Gjorstrup P, Pearlman E (2015) Inhibition of corneal inflammation by the resolvin E1. Invest Ophthalmol Vis Sci 56:2728\u20132736","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2_CR57","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.survophthal.2012.01.005","volume":"57","author":"AV Farooq","year":"2012","unstructured":"Farooq AV, Shukla D (2012) Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol 57:448\u2013462","journal-title":"Surv Ophthalmol"},{"key":"2_CR58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1001\/archopht.121.1.108","volume":"121","author":"DR Lairson","year":"2003","unstructured":"Lairson DR, Begley CE, Reynolds TF, Wilhelmus KR (2003) Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis. Arch Ophthalmol 121:108\u2013112","journal-title":"Arch Ophthalmol"},{"key":"2_CR59","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1001\/archopht.1989.01070020221029","volume":"107","author":"TJ Liesegang","year":"1989","unstructured":"Liesegang TJ, Melton L 3rd, Daly PJ, Ilstrup DM (1989) Epidemiology of ocular herpes simplex: incidence in Rochester, minn, 1950 through 1982. Arch Ophthalmol 107:1155\u20131159","journal-title":"Arch Ophthalmol"},{"key":"2_CR60","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0161-6420(02)01772-4","volume":"110","author":"PM Souza","year":"2003","unstructured":"Souza PM, Holland EJ, Huang AJ (2003) Bilateral herpetic keratoconjunctivitis. Ophthalmology 110:493\u2013496","journal-title":"Ophthalmology"},{"key":"2_CR61","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/ceo.12991","volume":"45","author":"M Tsatsos","year":"2017","unstructured":"Tsatsos M, MacGregor C, Athanasiadis I, Moschos MM, Jameel S, Hossain P, Anderson D (2017) Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents\u00a0\u2013 comment. Clin Exp Ophthalmol 45:932","journal-title":"Clin Exp Ophthalmol"},{"key":"2_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1386-6532(02)00263-9","volume":"26","author":"F Morfin","year":"2003","unstructured":"Morfin F, Thouvenot D (2003) Herpes simplex virus resistance to antiviral drugs. J Clin Virol 26:29\u201337","journal-title":"J Clin Virol"},{"key":"2_CR63","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1189\/jlb.3HI1216-511RR","volume":"102","author":"NK Rajasagi","year":"2017","unstructured":"Rajasagi NK, Bhela S, Varanasi SK, Rouse BT (2017) Frontline science: aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology. J Leukoc Biol 102:1159\u20131171","journal-title":"J Leukoc Biol"},{"key":"2_CR64","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1167\/iovs.14-14356","volume":"55","author":"J Hua","year":"2014","unstructured":"Hua J, Jin Y, Chen Y, Inomata T, Lee H, Chauhan SK, Petasis NA, Serhan CN, Dana R (2014) The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation. Invest Ophthalmol Vis Sci 55:5944\u20135951","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2_CR65","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4049\/jimmunol.1003456","volume":"186","author":"NK Rajasagi","year":"2011","unstructured":"Rajasagi NK, Reddy PBJ, Suryawanshi A, Mulik S, Gjorstrup P, Rouse BT (2011) Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. J Immunol 186:1735\u20131746","journal-title":"J Immunol"},{"key":"2_CR66","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s11745-004-1339-7","volume":"39","author":"CN Serhan","year":"2004","unstructured":"Serhan CN, Arita M, Hong S, Gotlinger K (2004) Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 39:1125\u20131132","journal-title":"Lipids"},{"key":"2_CR67","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.1167\/iovs.13-12152","volume":"54","author":"NK Rajasagi","year":"2013","unstructured":"Rajasagi NK, Reddy PB, Mulik S, Gjorstrup P, Rouse BT (2013) Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology. Invest Ophthalmol Vis Sci 54:6269\u20136279","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2_CR68","doi-asserted-by":"publisher","first-page":"43079","DOI":"10.1074\/jbc.M509796200","volume":"280","author":"A Ariel","year":"2005","unstructured":"Ariel A, Li PL, Wang W, Tang WX, Fredman G, Hong S, Gotlinger KH, Serhan CN (2005) The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering. J Biol Chem 280:43079\u201343086","journal-title":"J Biol Chem"},{"key":"2_CR69","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.4049\/jimmunol.176.3.1848","volume":"176","author":"CN Serhan","year":"2006","unstructured":"Serhan CN, Gotlinger K, Hong S, Lu Y, Siegelman J, Baer T, Yang R, Colgan SP, Petasis NA (2006) Anti-inflammatory actions of neuroprotectin D1\/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol 176:1848\u20131859","journal-title":"J Immunol"},{"key":"2_CR70","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.4049\/jimmunol.174.7.4345","volume":"174","author":"GL Bannenberg","year":"2005","unstructured":"Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, Hong S, Serhan CN (2005) Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol 174:4345\u20134355","journal-title":"J Immunol"},{"key":"2_CR71","doi-asserted-by":"publisher","first-page":"8491","DOI":"10.1073\/pnas.0402531101","volume":"101","author":"PK Mukherjee","year":"2004","unstructured":"Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG (2004) Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A 101:8491\u20138496","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR72","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1136\/bjo.81.11.965","volume":"81","author":"M Srinivasan","year":"1997","unstructured":"Srinivasan M, Gonzales CA, George C, Cevallos V, Mascarenhas JM, Asokan B, Wilkins J, Smolin G, Whitcher JP (1997) Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, South India. Br J Ophthalmol 81:965\u2013971","journal-title":"Br J Ophthalmol"},{"key":"2_CR73","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/00003226-200208000-00004","volume":"21","author":"U Gopinathan","year":"2002","unstructured":"Gopinathan U, Garg P, Fernandes M, Sharma S, Athmanathan S, Rao GN (2002) The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India. Cornea 21:555\u2013559","journal-title":"Cornea"},{"key":"2_CR74","first-page":"264","volume":"53","author":"S Deorukhkar","year":"2012","unstructured":"Deorukhkar S, Katiyar R, Saini S (2012) Epidemiological features and laboratory results of bacterial and fungal keratitis: a five-year study at a rural tertiary-care hospital in western Maharashtra, India. Singap Med J 53:264\u2013267","journal-title":"Singap Med J"},{"key":"2_CR75","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/jama.296.8.953","volume":"296","author":"DC Chang","year":"2006","unstructured":"Chang DC, Grant GB, O\u2019Donnell K, Wannemuehler KA, Noble-Wang J, Rao CY, Jacobson LM, Crowell CS, Sneed RS, Lewis FM (2006) Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA 296:953\u2013963","journal-title":"JAMA"},{"key":"2_CR76","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/archopht.124.7.ecr60006","volume":"124","author":"MD Bernal","year":"2006","unstructured":"Bernal MD, Acharya NR, Lietman TM, Strauss EC, McLeod SD, Hwang DG (2006) Outbreak of Fusarium keratitis in soft contact lens wearers in San Francisco. Arch Ophthalmol 124:1051\u20131053","journal-title":"Arch Ophthalmol"},{"key":"2_CR77","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.ophtha.2010.03.048","volume":"117","author":"EW Gower","year":"2010","unstructured":"Gower EW, Keay LJ, Oechsler RA, Iovieno A, Alfonso EC, Jones DB, Colby K, Tuli SS, Patel SR, Lee SM, Irvine J, Stulting RD, Mauger TF, Schein OD (2010) Trends in fungal keratitis in the United States, 2001\u20132007. Ophthalmology 117:2263\u20132267","journal-title":"Ophthalmology"},{"key":"2_CR78","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3109\/02713688609029240","volume":"5","author":"DM O\u2019Day","year":"1986","unstructured":"O\u2019Day DM, Head WS, Robinson RD, Clanton JA (1986) Corneal penetration of topical amphotericin B and natamycin. Curr Eye Res 5:877\u2013882","journal-title":"Curr Eye Res"},{"key":"2_CR79","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/bjo.2007.136515","volume":"92","author":"SM Hariprasad","year":"2008","unstructured":"Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR (2008) Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol 92:871\u2013878","journal-title":"Br J Ophthalmol"},{"key":"2_CR80","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJM200201243460403","volume":"346","author":"TJ Walsh","year":"2002","unstructured":"Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J, Yanovich S, Stiff P, Greenberg R, Donowitz G, Schuster M, Reboli A, Wingard J, Arndt C, Reinhardt J, Hadley S, Finberg R, Laverdi\u00e8re M, Perfect J, Garber G, Fioritoni G, Anaissie E, Lee J (2002) Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 346:225\u2013234","journal-title":"N Engl J Med"},{"key":"2_CR81","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJM200201243460403","volume":"346","author":"TJ Walsh","year":"2002","unstructured":"Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J, Yanovich S, Stiff P, Greenberg R, Donowitz G, Schuster M, Reboli A, Wingard J, Arndt C, Reinhardt J, Hadley S, Finberg R, Laverdiere M, Perfect J, Garber G, Fioritoni G, Anaissie E, Lee J, National Institute of, A., and Infectious Diseases Mycoses Study, G (2002) Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 346:225\u2013234","journal-title":"N Engl J Med"},{"key":"2_CR82","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1128\/CMR.00113-16","volume":"30","author":"ML Durand","year":"2017","unstructured":"Durand ML (2017) Bacterial and fungal endophthalmitis. Clin Microbiol Rev 30:597\u2013613","journal-title":"Clin Microbiol Rev"},{"key":"2_CR83","doi-asserted-by":"publisher","first-page":"e01537","DOI":"10.1128\/AAC.01537-18","volume":"62","author":"JM Guest","year":"2018","unstructured":"Guest JM, Singh PK, Revankar SG, Chandrasekar PH, Kumar A (2018) Isavuconazole for treatment of experimental fungal endophthalmitis caused by Aspergillus fumigatus. Antimicrob Agents Chemother 62:e01537\u2013e01518","journal-title":"Antimicrob Agents Chemother"},{"key":"2_CR84","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ajo.2010.01.024","volume":"149","author":"YC Shen","year":"2010","unstructured":"Shen YC, Wang CY, Tsai HY, Lee HN (2010) Intracameral voriconazole injection in the treatment of fungal endophthalmitis resulting from keratitis. Am J Ophthalmol 149:916\u2013921","journal-title":"Am J Ophthalmol"},{"key":"2_CR85","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1167\/iovs.13-13728","volume":"55","author":"PK Singh","year":"2014","unstructured":"Singh PK, Kumar A, Kumar A (2014) Resolvin D1 (RvD1) promotes the resolution of inflammation and protects mice from S. aureus endophthalmitis via toll-like receptor 2 signaling. Invest Ophthalmol Vis Sci 55:3575\u20133575","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2_CR86","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature11042","volume":"484","author":"N Chiang","year":"2012","unstructured":"Chiang N, Fredman G, Backhed F, Oh SF, Vickery T, Schmidt BA, Serhan CN (2012) Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484:524\u2013528","journal-title":"Nature"},{"key":"2_CR87","doi-asserted-by":"publisher","first-page":"3242649","DOI":"10.1155\/2017\/3242649","volume":"2017","author":"H Eguchi","year":"2017","unstructured":"Eguchi H, Hiura A, Nakagawa H, Kusaka S, Shimomura Y (2017) Corneal nerve fiber structure, its role in corneal function, and its changes in corneal diseases. Biomed Res Int 2017:3242649","journal-title":"Biomed Res Int"},{"key":"2_CR88","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/j.ophtha.2015.06.047","volume":"122","author":"RT Muller","year":"2015","unstructured":"Muller RT, Abedi F, Cruzat A, Witkin D, Baniasadi N, Cavalcanti BM, Jamali A, Chodosh J, Dana R, Pavan-Langston D, Hamrah P (2015) Degeneration and regeneration of subbasal corneal nerves after infectious keratitis: a longitudinal in vivo confocal microscopy study. Ophthalmology 122:2200\u20132209","journal-title":"Ophthalmology"},{"key":"2_CR89","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jtos.2016.09.004","volume":"15","author":"A Cruzat","year":"2017","unstructured":"Cruzat A, Qazi Y, Hamrah P (2017) In vivo confocal microscopy of corneal nerves in health and disease. Ocul Surf 15:15\u201347","journal-title":"Ocul Surf"},{"key":"2_CR90","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/jcp.25623","volume":"232","author":"L Mastropasqua","year":"2017","unstructured":"Mastropasqua L, Massaro-Giordano G, Nubile M, Sacchetti M (2017) Understanding the pathogenesis of neurotrophic keratitis: the role of corneal nerves. J Cell Physiol 232:717\u2013724","journal-title":"J Cell Physiol"},{"key":"2_CR91","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1167\/iovs.09-3641","volume":"51","author":"MS Cortina","year":"2010","unstructured":"Cortina MS, He J, Li N, Bazan NG, Bazan HE (2010) Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA. Invest Ophthalmol Vis Sci 51:804\u2013810","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2_CR92","doi-asserted-by":"publisher","first-page":"18486","DOI":"10.1074\/jbc.M117.801472","volume":"292","author":"TL Pham","year":"2017","unstructured":"Pham TL, He J, Kakazu AH, Jun B, Bazan NG, Bazan HEP (2017) Defining a mechanistic link between pigment epithelium\u2013derived factor, docosahexaenoic acid, and corneal nerve regeneration. J Biol Chem 292:18486\u201318499","journal-title":"J Biol Chem"},{"key":"2_CR93","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.plefa.2012.03.010","volume":"88","author":"S Kenchegowda","year":"2013","unstructured":"Kenchegowda S, He J, Bazan HE (2013) Involvement of pigment epithelium-derived factor, docosahexaenoic acid and neuroprotectin D1 in corneal inflammation and nerve integrity after refractive surgery. Prostaglandins Leukot Essent Fatty Acids 88:27\u201331","journal-title":"Prostaglandins Leukot Essent Fatty Acids"}],"container-title":["Advances in Experimental Medicine and Biology","The Role of Bioactive Lipids in Cancer, Inflammation and Related Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-21735-8_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T13:05:34Z","timestamp":1569589534000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-21735-8_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030216368","9783030217358"],"references-count":93,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-21735-8_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"28 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}